Market revenue in 2023 | USD 344.0 million |
Market revenue in 2030 | USD 486.9 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 31.8% in 2023. Horizon Databook has segmented the Sweden oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden holds a strong position in drug development space. The current scenario for pharmaceutical CMOs & CROs in Sweden is that the country has a well-established and growing pharmaceutical industry, which is known for its innovation and research.
The country's pharmaceutical industry is very strategic, focusing on world-class innovation and excellent R&D. In Sweden, oral solid dosage contract manufacturing plays a crucial role in developing new pharmaceuticals such as oral solid dosage drugs.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Sweden oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account